Oelkrug C - Search Results

1

IgY antibodies: The promising potential to overcome antibiotic resistance.

El-Kafrawy SA, Abbas AT, Oelkrug C, Tahoon M, Ezzat S, Zumla A, Azhar EI. El-Kafrawy SA, et al. Among authors: oelkrug c. Front Immunol. 2023 Jan 20;14:1065353. doi: 10.3389/fimmu.2023.1065353. eCollection 2023. Front Immunol. 2023. PMID: 36742328 Free PMC article. Review.

2

IgY Targeting Bacterial Quorum-Sensing Molecules in Implant-Associated Infections.

Dapunt U, Prior B, Oelkrug C, Kretzer JP. Dapunt U, et al. Among authors: oelkrug c. Molecules. 2020 Sep 3;25(17):4027. doi: 10.3390/molecules25174027. Molecules. 2020. PMID: 32899313 Free PMC article.

3

Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells.

Hilger N, Glaser J, Müller C, Halbich C, Müller A, Schwertassek U, Lehmann J, Ruschpler P, Lange F, Boldt A, Stahl L, Sack U, Oelkrug C, Emmrich F, Fricke S. Hilger N, et al. Among authors: oelkrug c. Cytometry A. 2016 Sep;89(9):803-15. doi: 10.1002/cyto.a.22930. Epub 2016 Aug 25. Cytometry A. 2016. PMID: 27560708 Free article.

4

IgY antibodies in human nutrition for disease prevention.

Müller S, Schubert A, Zajac J, Dyck T, Oelkrug C. Müller S, et al. Among authors: oelkrug c. Nutr J. 2015 Oct 20;14:109. doi: 10.1186/s12937-015-0067-3. Nutr J. 2015. PMID: 26487372 Free PMC article. Review.

5

Novel in vitro platform to investigate myotube atrophy.

Oelkrug C, Horn K, Makert GR, Schubert A. Oelkrug C, et al. Anticancer Res. 2015 Apr;35(4):2085-91. Anticancer Res. 2015. PMID: 25862864

6

Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.

Schmidt F, Hilger N, Oelkrug C, Svanidze E, Ruschpler P, Eichler W, Boldt A, Emmrich F, Fricke S. Schmidt F, et al. Among authors: oelkrug c. Cytometry A. 2015 Apr;87(4):334-45. doi: 10.1002/cyto.a.22619. Epub 2015 Feb 24. Cytometry A. 2015. PMID: 25717029 Free article.

7

Mode of action of anticancer peptides (ACPs) from amphibian origin.

Oelkrug C, Hartke M, Schubert A. Oelkrug C, et al. Anticancer Res. 2015 Feb;35(2):635-43. Anticancer Res. 2015. PMID: 25667440 Review.

8

Allogeneic bone marrow grafts with high levels of CD4⁺ CD25⁺ FoxP3⁺ T cells can lead to engraftment failure.

Fricke S, Rothe K, Hilger N, Ackermann M, Oelkrug C, Fricke C, Schönfelder U, Niederwieser D, Emmrich F, Sack U. Fricke S, et al. Among authors: oelkrug c. Cytometry A. 2015 Mar;87(3):279-280. doi: 10.1002/cyto.a.22639. Epub 2015 Jan 28. Cytometry A. 2015. PMID: 25631159 Free article. No abstract available.

9

Novel imidazolium salt--peptide conjugates and their antimicrobial activity.

Reinhardt A, Horn M, Schmauck JP, Bröhl A, Giernoth R, Oelkrug C, Schubert A, Neundorf I. Reinhardt A, et al. Among authors: oelkrug c. Bioconjug Chem. 2014 Dec 17;25(12):2166-74. doi: 10.1021/bc500510c. Epub 2014 Dec 8. Bioconjug Chem. 2014. PMID: 25428117

10

Antibody- and aptamer-strategies for GvHD prevention.

Oelkrug C, Sack U, Boldt A, Nascimento IC, Ulrich H, Fricke S. Oelkrug C, et al. J Cell Mol Med. 2015 Jan;19(1):11-20. doi: 10.1111/jcmm.12416. Epub 2014 Oct 29. J Cell Mol Med. 2015. PMID: 25353670 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page